Titan Medical Reports Financial Results for the Third Quarter 2022, and Announces Special Shareholder Meeting
TORONTO, Nov. 10, 2022 (GLOBE NEWSWIRE) — Titan Medical Inc. (Nasdaq:TMDI; TSX:TMD), a medical device company focused on the development and commercialization of innovative surgical technologies for single access robotic-assisted surgery (RAS), today announced financial results for the three and nine months ended September 30, 2022. Additionally, the company announced that a special meeting of shareholders will be held virtually on January 12, 2023 to seek shareholder approval for a consolidation of its common shares, including for the purposes of demonstrating compliance with Nasdaq Rule 5550(a)(2).